Live Breaking News & Updates on Telmar Network Technology

Stay updated with breaking news from Telmar network technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UCR's School of Medicine expands on its research on stuttering


Highlander
Post Views:
1,658
UCR’s School of Medicine is partnering with Emalex Biosciences in producing a biological treatment for stuttering and will lead the second phase of clinical trials.
UCR will serve as the lead site for a Phase 2 clinical trial that will evaluate the effectiveness of ecopipam, an investigational drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients. Emalex Biosciences who developed ecopipam, will conduct the clinical trial. Ecopipam currently treats talk and speech therapy. However, if the trials continue to show success and are later submitted to the U.S. Food and Drug Administration (FDA), ecopipam could become the leading biological medication to treat stuttering with FDA approval. Furthermore, ecopipam has the possibility of also treating children with Tourette syndrome, a type of disorder which involves “involuntary, repetitive movements and vocalization.” ....

United States , Gerald Maguire , Granville Kirkup , Emalex Biosciences , University Of California , Telmar Network Technology , School Of Medicine , Drug Administration , Post Views , National Stuttering , ஒன்றுபட்டது மாநிலங்களில் , ஜெரால்ட் மக்வைர் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , டெல்மார் வலைப்பின்னல் தொழில்நுட்பம் , பள்ளி ஆஃப் மருந்து , போஸ்ட் காட்சிகள் , தேசிய திணறல் ,